Evidence map›Paper›PMID 16118206›Full record

ArticleThe Journal of biological chemistry2005

Rational design of p53, an intrinsically unstructured protein, for the fabrication of novel molecular sensors.

Melissa L Geddie, Taryn L O'Loughlin, Kristen K Woods, Ichiro Matsumura

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Converting a protein into a switch for biosensing and functional regulation.Protein science : a publication of the Protein Society · 2011
    Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Melissa L GeddieDepartment of Biochemistry, Center for Fundamental and Applied Molecular Evolution, Emory University School of Medicine, Atlanta, Georgia 30322, USA.
Taryn L O'Loughlin
Kristen K Woods
Ichiro Matsumura
Emory University · US

Funding

Engineered alkaline phosphatases as biosensorsR21AI054602 · NIAID · EMORY UNIVERSITY · PI MATSUMURA, ICHIRO · 2003 to 2004
$532k
NIAID NIH HHS 1 R21AI054602-01NIAID NIH HHS R21 AI054602
6 · The paper itself

Abstract

The dominant paradigm of protein engineering is structure-based site-directed mutagenesis. This rational approach is generally more effective for the engineering of local properties, such as substrate specificity, than global ones such as allostery. Previous workers have modified normally unregulated reporter enzymes, including beta-galactosidase, alkaline phosphatase, and beta-lactamase, so that the engineered versions are activated (up to 4-fold) by monoclonal antibodies. A reporter that could easily be "reprogrammed" for the facile detection of novel effectors (binding or modifying activities) would be useful in high throughput screens for directed evolution or drug discovery. Here we describe a straightforward and general solution to this potentially difficult design problem. The transcription factor p53 is normally regulated by a variety of post-translational modifications. The insertion of peptides into intrinsically unstructured domains of p53 generated variants that were activated up to 100-fold by novel effectors (proteases or antibodies). An engineered p53 was incorporated into an existing high throughput screen for the detection of human immunodeficiency virus protease, an arbitrarily chosen novel effector. These results suggest that the molecular recognition properties of intrinsically unstructured proteins are relatively easy to engineer and that the absence of crystal structures should not deter the rational engineering of this class of proteins.

Indexed as

Alkaline PhosphataseAntibodies, MonoclonalBacillus anthracisbeta-Galactosidasebeta-LactamasesCell MembraneCrystallography, X-RayEscherichia coliGenes, ReporterGenetic VariationGenetic VectorsHIVHIV ProteaseHumansModels, GeneticMutagenesis, Site-DirectedAlkaline PhosphataseAntibodies, Monoclonalbeta-Galactosidasebeta-LactamasesHIV ProteasePeptidesTumor Suppressor Protein p53

Identifiers

PMID16118206
PMCPMC2045634
OpenAlexW2092240541

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.